Topical genistein ameliorated the murine IMQ-induced psoriasiform dermatitis with the reduction of skin score, epidermal thickness, and of IL-1β, IL-6, TNF-α, CCL2, IL-17, and IL-23 expression in the skin lesions [73]. The gene discussed is IL37; the disease is Psoriasiform dermatitis.